Skip to content

HEARING: Boustany Announces Hearing on the Impact of Limitations on the Use of Tax-Advantaged Accounts for the Purchase of Over-the-Counter Medication

April 25, 2012

Focus Of The Hearing:
The hearing will focus on reviewing the rules affecting FSAs, HSAs and HRAs and the impact the rules have on consumers, physicians, and employers.

Witness List:

Mr. Scott M. Melville
President & Chief Executive Officer, Consumer Healthcare Products Association
Testimony
(Truth in Testimony)

Dr. Joel M. Feder
D.O., F.A.C.O.F.P., Captain MC, USN (Ret.), American Osteopathic Association
Testimony
(Truth in Testimony)

Mr. Steven Taylor
Chief Executive Officer, Sjogren’s Syndrome Foundation
Testimony
(Truth in Testimony)

Ms. Jennifer Hatcher
Senior Vice President, Government & Public Affairs, Food Marketing Institute
Testimony
(Truth in Testimony)

Mr. Paul N. Van de Water
Senior Fellow, Center on Budget and Policy Priorities
Testimony
(Truth in Testimony)


Transcript